Liver Apparent Diffusion Coefficient Changes during Telaprevir-Based Therapy for Chronic Hepatitis C.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27994911)

Published in Balkan Med J on November 01, 2016

Authors

Nagihan İnan Gürcan1, Zakir Sakçı1, Sıla Akhan2, Elif Sargın Altunok2, Aynur Aynıoğlu2, Yeşim Gürbüz3, Hasan Tahsin Sarisoy1, Gür Akansel1

Author Affiliations

1: Department of Radiology, Kocaeli University School of Medicine, Kocaeli, Turkey.
2: Department of Infectious Diseases and Clinical Microbiology, Kocaeli University School of Medicine, Kocaeli, Turkey.
3: Department of Pathology, Kocaeli University School of Medicine, Kocaeli, Turkey.

Articles cited by this

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology (1982) 11.24

Liver cirrhosis: intravoxel incoherent motion MR imaging--pilot study. Radiology (2008) 4.46

MR elastography of the liver: preliminary results. Radiology (2006) 3.20

Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging. Radiology (2006) 2.23

Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience. AJR Am J Roentgenol (2007) 2.02

[Diagnosis and quantification of hepatic fibrosis with diffusion weighted MR imaging: preliminary results]. J Radiol (2004) 1.89

Assessment of chronic hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imaging. AJR Am J Roentgenol (2011) 1.62

Advanced liver fibrosis: diagnosis with 3D whole-liver perfusion MR imaging--initial experience. Radiology (2008) 1.62

Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. Hepatology (2007) 1.58

Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosis. J Magn Reson Imaging (2005) 1.45

Diffusion-weighted imaging of the abdomen at 3.0 Tesla: image quality and apparent diffusion coefficient reproducibility compared with 1.5 Tesla. J Magn Reson Imaging (2011) 1.34

Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging--preliminary observations. Radiology (2011) 1.31

Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis C. Hepatology (2014) 0.98

Triple therapy for HCV genotype 1 infection: telaprevir or boceprevir? Liver Int (2012) 0.92

Diagnostic performance of conventional diffusion weighted imaging and diffusion tensor imaging for the liver fibrosis and inflammation. Eur J Radiol (2012) 0.92

Characterization of hepatic lesions by perfusion-weighted MR imaging with an echoplanar sequence. AJR Am J Roentgenol (1998) 0.88

Triple therapy with telaprevir: results in hepatitis C virus-genotype 1 infected relapsers and non-responders. Liver Int (2012) 0.87

Boceprevir and telaprevir-based triple therapy for chronic hepatitis C: virological efficacy and impact on kidney function and model for end-stage liver disease score. J Viral Hepat (2014) 0.85

Is water diffusion isotropic in the cirrhotic liver? a study with diffusion-weighted imaging at 3.0 Tesla. Acad Radiol (2011) 0.81

Articles by these authors

Resveratrol attenuates both small bowel and liver changes in obstructive jaundice. Balkan Med J (2014) 0.75